Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug-Use Surveillance Study on Entyvio for IV Infusion 300 mg [Ulcerative Colitis]

NCT03824561 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03824561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03824561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug-Use Surveillance Study on Entyvio for IV Infusion 300 mg [Ulcerative Colitis]
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
February 1, 2019
Completion date
February 12, 2025
Enrollment
1,110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis